Deal date

KANDO id: 1050208

Financial Transaction:

Series A


Blossomhill Therapeutics Inc


Currency
United States Dollar
Value in original currency
71,000,000
Value in USD
71,000,000

Lead investor

Country Notes

Cormorant Asset Management

Initial investment.

Round participants

Country Notes

Hercules BioVentures

Initial investment.

OrbiMed Advisors LLC

American investment firm focused on making public and private investments in the healthcare and biotechnology industries.
United States Initial investment.

Vivo Capital

Initial investment.